A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine and University Hospital Cologne has ...

There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

A new immune structure found in liver tumors could improve treatment for liver cancer patients. These structures are linked ...

Researchers discovered that cordycepin, derived from the caterpillar fungus Cordyceps militaris, disrupts cancer cell growth ...

A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical ...

Novel method identified protein degraders that target Pin1, a protein involved in pancreatic cancer development.